AXBIO (安序源)
- Business Model
- B2B
- Website
- axbio.com
- Total Funding
- $100.0M
- Last Round
- $100.0M Series AJun 2022
- Rounds
- 1
About
Single-molecule gene sequencing and diagnostic device R&D company
Summary
AXBIO (安序源) is a Biotech company. It has raised $100.0M in total across 1 round, most recently a $100.0M Series A round in Jun 2022. Investors include 5Y Capital, AstraZeneca-CICC Healthcare Industrial Fund and Kaitai Capital.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2022
Investors
Similar Companies
Leading interactive entertainment company and developer of Fortnite, Unreal Engine, and the Epic ...
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Cursor is the best way to code with AI, and built to make you extraordinarily productive.
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...